<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> is considered ineligible for hematopoietic stem cell transplantation (HSCT) </plain></SENT>
<SENT sid="1" pm="."><plain>We report a 49-year-old woman with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) complicated by refractoriness to platelet transfusion and <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo>, who underwent allogeneic bone marrow transplantation from an HLA-identical unrelated male donor </plain></SENT>
<SENT sid="2" pm="."><plain>Nine days before the scheduled transplantation, she developed <z:hpo ids='HP_0001260'>dysarthria</z:hpo> and right <z:hpo ids='HP_0001269'>hemiparesis</z:hpo>; computed tomography (CT) of the brain disclosed an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0008817'>hematoma</z:mp> in the left parietal lobe exceeding 3 cm in diameter </plain></SENT>
<SENT sid="3" pm="."><plain>She underwent conditioning with reduced-intensity, including fludarabine (30 mg/m2/day on days -8 to -3), <z:chebi fb="0" ids="28901">busulfan</z:chebi> (4 mg/kg/day on days -6 and -5), and total body irradiation (4 Gy on day -2) </plain></SENT>
<SENT sid="4" pm="."><plain>Two weeks after transplantation, <z:hpo ids='HP_0001260'>dysarthria</z:hpo> and right <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> began to resolve, and CT showed spontaneous resolution of the <z:mp ids='MP_0008817'>hematoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Simultaneously, engraftment was confirmed </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, recent <z:hpo ids='HP_0001297'>stroke</z:hpo> may be not an absolute contraindication for HSCT </plain></SENT>
</text></document>